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Abstract
Purpose Pre-term infants are at risk of abnormal
visual development that can range from subtle to
severe. The aim of this study was to compare flash
VEPs in clinically stable pre-term and full-term
infants at 6 months of age.
Methods Twenty-five pre-term and 25 full-term
infants underwent flash VEP testing at the age of
6 months. Monocular VEPs were recorded using flash
goggles on a RETIscan system under normal sleeping
conditions. Amplitude and peak time responses of the
P2 component in the two eyes were averaged and
compared between the two groups. Multiple regres-
sion analyses were performed to assess the relation-
ship of the P2 responses with birth weight (BW) and
gestational age (GA).
Results At 6 months corrected age, pre-term infants
had significantly delayed P2 peak times than full-term
infants (mean difference: 10.88 [95% CI 4.00–17.76]
ms, p = 0.005). Pre-term infants also showed signif-
icantly reduced P2 amplitudes as compared to full-
term infants (mean difference: 2.36 [0.83–3.89] lV,
p = 0.003). Although the regression model with GA
and BW as fixed factors explained 20% of the variance
in the P2 peak time (F2,47 = 5.98, p = .0045), only GA
showed a significant negative relationship
(b = -2.66, p = .003). Neither GA (b = 0.21,
p = .28) nor BW (b = 0.001, p = .32) showed any
relationship with P2 amplitude.
Conclusions Our results demonstrate that, compared
with full-term infants, clinically stable pre-term
infants exhibit abnormal flash VEPs, with a delay in
P2 peak time and a reduction in P2 amplitude. These
findings support a potential dysfunction of the visual
pathway in clinically stable pre-term infants as
compared to full-term infants.
Keywords Flash VEP  Full-term  Infants  Pre-
term  Visual evoked potential
Introduction
Approximately one in ten babies are born pre-term
every year [1], with the rate of pre-term birth ranging
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from 5 to 18% across different regions of the world [2].
There is an extensive amount of literature on the effect
of pre-term birth on visual [3, 4] and neurological
development [5]. Pre-term children are at a higher risk
of abnormal visual and neurological development than
their full-term peers. Ocular and visual deficits such as
retinopathy of prematurity, refractive errors and
cortical visual impairment are common in pre-term
infants [6, 7]. Mild-to-severe structural alterations of
several brain areas including the cortical and extra-
cortical visual areas are also observed in pre-term
infants [8].
Visual evoked potential (VEP) is a minimally
invasive investigative procedure that provides a func-
tional probing of the visual pathway in infants and has
long been used to explore functional deficits in the
visual pathway of the pre-term brain [9]. VEP is
particularly useful to investigate the functional
integrity of the visual system of high-risk infants
where obvious retinal and neurological abnormalities
are not observed [10]. Several flash VEP studies of
high-risk infants are available in the literature [11–15].
These studies have demonstrated that immature P2
waveform [11], irreproducible waveform responses,
and unrecordable VEP measurements [13] are associ-
ated with abnormal neurodevelopment [12] and visual
impairment in pre-term infants. VEP has also been
investigated for its prognostic value of long-term
visual and neurodevelopmental outcomes in infants
[16–18] but the results are ambiguous. While most
studies have demonstrated that early flash VEP in
infants is predictive of long-term neurodevelopmental
or visual status, some studies have shown contrasting
findings [19].
Clinically or medically stable pre-term infants
(infants with no signs of infection, severe desaturation
and bradycardia, and not requiring invasive respira-
tory support) are also considered to be at high risk of
abnormal neurodevelopment [5] and can have several
neurological insults [20]. However, very little is
understood on whether these infants differ from their
full-term counterparts with regard to the development
and maturation of the visual pathway. In this study, we
sought to investigate the effect of pre-term birth on
visual cortical pathway as assessed with flash VEP.
We also explored any presence of refractive errors in
this specific population.
Methods
Participants
Twenty-five pre-term (18 males and 7 females) and 25
full-term infants (13 males and 12 females) partici-
pated in this study. Infants were recruited from the
Paediatric Department of Tribhuvan University
Teaching Hospital and Paediatric Ophthalmology unit
of B.P. Koirala Lions Centre for Ophthalmic Studies
in Kathmandu, Nepal. All parents provided written
informed consent for their children to participate in the
study. The institutional ethical review committee of
the Institute of Medicine provided ethical approval for
the study. Pre-term infants were eligible for partici-
pation if they were clinically stable and had (1)
Gestational age (GA) of 37 weeks or younger, (2)
Birth weight (BW) less than 2500 g, (3) no systemic
complications of meningitis, cerebral palsy, brain
damage, birth asphyxia, stroke, congenital malforma-
tions, genetic or chromosomal abnormalities and (4)
absence of congenital cataract, congenital glaucoma,
retinopathy of prematurity or other major complica-
tions. Out of the 25 pre-term infants, five were very
pre-term (GA\ 32 weeks), 20 were moderate to late
pre-term (GA between 32 and 37 weeks), four had
very low BW (1000 to \ 1500 g) and 21 had low BW
(1500 to\ 2000 g). Infants were categorised based on
the WHO criteria [21]. None of the pre-term infants
had extremely low BW (\ 1000 g). To facilitate the
comparison with a control group, the study included
healthy age-matched infants born at term. All of these
full-term infants had (1) GA greater than 37 weeks;
(2) birth weight appropriate for GA and more than
2500 g; (3) normal infant vital parameters at the time
of birth; and (4) APGAR score (Appearance, Pulse,
Grimace, Activity, Respiration) greater than 7 at the
time of birth.
Study protocol
Neonatal and antenatal history of the infants, including
birth parameters, were obtained from their medical
records. All infants were enrolled consecutively for
cross-sectional measurements. Pre-term infants were
examined at 6 months (± 1 week) of their corrected
age, whereas full-term infants were examined at
6 months (± 1 week) of their chronological age. All
examinations were conducted in the presence of
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parents or caretakers of infants. For all participating
infants, a paediatric ophthalmologist performed
detailed ophthalmic examination (anterior and poste-
rior segment) to determine the ocular health, while a
qualified optometrist conducted the measurements of
refractive error and VEP recordings. Pupils of both
eyes were dilated using a cycloplegic (1% Cyclopen-
tolate Hydrochloride) eye drop instilled 3 times at an
interval of 10 min. Refractive error was measured by
performing objective retinoscopy at a distance of
50 cm after 30 min from the time of the last instilla-
tion of cycloplegic drug. Refractive error was classi-
fied as myopia when the spherical equivalent
refractive error (SER) was B - 0.50 and as hyperopia
when SER was C ? 0.50D. All procedures in the
study adhered to the tenets of the Declaration of
Helsinki.
Flash VEP recording
All infants underwent VEP tests on a separate session
to that of retinoscopy under normal deep sleep state
(i.e. regular breathing, eyes closed with no eye
movements, no spontaneous activities except startles
or jerky movements) while laying on their parent’s lap.
None of these infants received any medication (e.g.
sedation/analgesia). Responses were recorded using
standard gold-plated cup electrodes (10 mm, with
2 mm centre hole) on a RETIscan system (Roland
Consult, Germany) in accordance with the ISCEV
clinical flash VEP standard [22] other than deviations
as mentioned below. Active electrode was placed on
the occipital scalp, 2 cm above the inion according to
the International 10/20 electrode placement system
(10% of the nasion-to-inion separation). Reference
electrode was placed on the frontal scalp, and ground
electrode on the parietal scalp. Retinal stimulation was
done monocularly over closed eyelids using light
emitting diode flash goggles that delivered red flashes
of strength 3 photopic cd s/m2 every 30 s (2 Hz). The
shield provided by the goggles ensured no light entered
the unstimulated eye, which was occluded throughout
the recording period. No topical eye drops were
instilled during VEP measurements. The skin was
prepared using an abrasive cream (NuPrep, Weaver
and Company, USA) to reduce the resistance prior to
the application of the electrodes on the scalp with
conductive paste (TEN20, Weaver and Company,
USA). During the VEP recordings, impedance for each
electrode was maintained at less than 5 kX and band
pass filters set at- 0.5 to 50 Hz. An in-built automatic
artefact rejection algorithm was used to reject blink
artefacts above a threshold of 90% of the range. In the
event of excessive artefacts, the trial was rejected and
the measurement repeated. VEPs were obtained in two
trials, each with 100 measures, and averaged. The
built-in RETIport software automatically displayed
cursors corresponding to the peaks and troughs of the
VEP waveforms. In addition, the software allowed
manual repositioning of the cursors. One of the
investigators, who has several years of experience
with VEP examination, reviewed all waveforms retro-
spectively and manually shifted cursor positions on
occasional cases of misalignment. The same investi-
gator assessed the reproducibility of waveforms of the
two trials in each infant by visual inspection immedi-
ately after completion of the tests. Subjects with
variable trails underwent repeat testing on the follow-
ing day or were excluded. Altogether, VEPs from 5
pre-term and 3 full-term infants were discarded
because of instrument-related (excessive artefacts,
high impedance) and subject-related factors (lack of
co-operation and lost follow-up for repeat testing),
leaving data from 25 pre-term and 25 full-term subjects
available for analysis. Previous studies have shown P2
component to be the most prominent and robust
component of flash VEP [15, 23]. Therefore, following
the completion of the tests, P2 parameters (amplitudes
and peak times) were obtained using a built-in
RETIport software v4.8.1.12 and compared between
the groups. Peak time was calculated as the time from
stimulus onset to the peak of the P2 component,
whereas P2 amplitude was measured from the preced-
ing negative peak N2 to the positive peak P2 (Fig. 1).
Statistical analysis
Data were analysed in R [24] and figures were created
using the package ggplot2 [25]. Spherical equivalent
refractive error (SER) was calculated as sphere ?
cylinder
2
 
in dioptres (D). Significant correlations were
observed between data in right eye and left eye (ICC,
SER: 0.92 [0.87,0.96], p\ 0.0001; P2 peak time: 0.85
[0.73, 0.91], p\ 0.0001, P2 amplitude: 0.71 [0.54,
0.82], p\ 0.0001). Therefore, average data from two
eyes were used for analysis [26]. Normality of the data
was tested with Shapiro–Wilk test and verified with
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histograms and Q–Q plots. Data on refraction and peak
times were normally distributed for both pre-term and
full-term cohorts (all p[ 0.05), but average amplitude
data (mean of two eyes) were not (p = 0.002).
Therefore, differences between pre-term and full-term
infants were tested for significance with Wilcoxon-
Mann–Whitney test for independent samples. The two
independent variables were only moderately corre-
lated (r = 0.38), thus meeting the multicollinearity
assumption. General linear models with GA and BW
as fixed effects were carried out to investigate whether
GA and BW could significantly affect flash VEP
outcome variables. Separate models were constructed
for P2 peak times and amplitudes. Relationship of
residual and predicted values showed that the data
were homoscedastic. In addition, distributions of
residuals were normal, and there were no influential
outliers as assessed with Cook’s distance. Data are
presented as mean ± SD and mean difference [95%
CI], unless otherwise stated. P value of\ 0.05 is
considered to be statistically significant. Since P2
amplitudes and peak times were not independent of
each other, comparisons of these outcomes between
the two groups used Bonferroni-corrected alpha of
0.025. As limited number of infants were allocated to
each cohort based on convenience sampling due to
limited resources and short duration of the project,
effect sizes and posthoc power calculations for two-
sided tests at 0.05 significance level were performed.
Results
Pre-term infants had significantly lower GA (mean
difference: 5.51 [4.58–6.45] weeks, p\ 0.001) and
BW (mean difference: 808 [627–989] g; p\ 0.001)
(Table 1). No significant association was observed
between gender distribution and infant’s birth status
(i.e. pre-term or full-term) (v2 = 2.12, p = 0.14).
Refractive Error
Nine out of 25 (36%) pre-term infants were myopic,
whereas only one out of 25 (4%) full-term infants were
myopic. Average SER was 0.31 ± 0.99 D in pre-term
infants and 0.92 ± 0.52 D in full-term infants. There
was a statistically significant difference in average
SER (mean of two eyes) between the pre-term and
full-term infants, with the pre-term infants showing a
relative bias towards myopia (mean difference = 0.64
[0.18–1.10], p = 0.03, effect size d = 0.77, power =
0.74, Fig. 2a). Inter-eye difference of mean SER was
0.13 ± 0.42 D in pre-term infants and 0.05 ± 0.20 D
in full-term infants.
P2 peak times and amplitudes
Pre-term infants showed delayed P2 peak times
(133.3 ± 12.7 ms) compared to full-term infants
(122.4 ± 11.4 ms); this difference in peak times was
statistically significant (mean difference = 10.88
[4.00–17.76] ms, p = 0.005, effect size d = 0.90,
power = 0.87, Fig. 2B). Similarly, pre-term infants
demonstrated reduced P2 amplitudes
(6.84 ± 2.10 lV) in comparison with the full-term
infants (9.20 ± 3.18 lV) with a statistically signifi-
cant difference in amplitudes (mean difference = 2.36
[0.83–3.89] lV, p = 0.003, effect size d = 0.88,
power = 0.84, Fig. 2c).
Fig. 1 Flash VEP waveforms showing negative wave N2 and positive wave component P2 from the left eye of a pre-term and a full-
term infant. The waveforms are replotted from software-generated reports
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Relationship of P2 parameters with GA and BW
We further explored the relationship of P2 parameters
(peak times and amplitudes) with GA and BW by
conducting multiple linear regression analyses, with
GA and BW as fixed factors. The results of the
regression indicated that the model for the peak time
explained 20% of the variance and that themodel was a
significant predictor (F2,47 = 5.98, p = 0.0045, effect
size f2 = 0.25, power = 0.88, Fig. 3a). In particular,
GA contributed significantly to the model (b = -2.66,
p = 0.003); peak time was delayed by 2.66 ms for
every one-week reduction in gestational age. However,
BW did not have an effect on peak times (b = -0.01,
p = 0.14). The final predictive model was: P2 Peak
time = 205.89 ? (- 2.66*GA) ? (0.01*BW).
For the amplitude model, GA and BW only
explained 18% of variance in the P2 amplitudes.
Although the multiple regression model was a signif-
icant predictor of P2 amplitudes (F2,47 = 5.03,
p = 0.01, effect size f2 = 0.22, power = 0.83,
Fig. 3b), the fixed effects of both GA (b = 0.21,
p = 0.28) and BW (b = 0.001, p = 0.32) were not
Table 1 Distribution of
pre-term and full-term
infants in terms of
gestational age and birth
weight
NA not applicable, GA
Gestational age, BW birth
weight
*Independent sample t test
Pre-term Full-term p value 95% CI of diff [lower, upper]
Frequency (n) 25 25
GA (weeks)
28 to\ 32 5 (20%) NA
32 to\ 37 20 (80%) NA
[ 37 to 42 NA 25 (100%)
Mean ± 95% CI 33.83 ± 0.86 39.34 ± 0.44 < 0.001* [- 6.45 to - 4.58]
Range 30.43–37.00 38.00–41.71
Birth weight (g)
1000 to\ 1500 4 (16%)
1500 to\ 2500 21 (84%) NA
C 2500 NA 25 (100%)
Mean ± 95% CI 1996 ± 163.27 2804 ± 97.34 < 0.001* [- 989 to - 627]
Range 1300–2450 2500–3300
Fig. 2 a Average spherical equivalent refractive error (SER,
mean of two eyes), b P2 peak times and c P2 amplitudes of pre-
term and full-term infants. There were significant differences in
SER, P2 peak times and amplitudes between the pre-term and
full-term infants. Dark red error bars inside the boxplot represent
mean ± SEM. Filled and open-circle symbols represent pre-
term and full-term infants, respectively. Each colour matches
infants in the two cohorts. SER spherical equivalent refraction,
D dioptre, ms milliseconds, lV microvolts
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significant. The final predictive model was: P2
Amplitude = - 2.52 ? 0.21*(GW) ? 0.001*(BW).
Discussion
This study evaluated refractive status and flash VEP
parameters in a cohort of clinically stable pre-term
infants and examined whether these parameters are
different when compared with an age-matched cohort
of full-term infants. Furthermore, the study explored
the relationship between the VEPs with two common
birth parameters: GA and BW. Our results indicate
that clinically stable pre-term infants may have altered
emmetropization [27] since a higher number of pre-
term infants demonstrated myopic refractive errors
than their full-term peers. This finding is consistent
with previous studies that suggest children born pre-
term are at a higher risk of developing myopia
[28–30]. With regard to the VEP parameters, pre-term
infants had relatively prolonged and diminished VEPs
than their full-term counterparts. These findings
suggest an abnormal cortical neural activity in pre-
term infants despite their clinical stability and indicate
potential immaturity of the global visual pathway. Our
results further show that the birth parameter GA has
negative relationship with the VEPs wherein children
with shorter gestation period at birth are likely to show
altered VEPs with delayed peak times. However, birth
weight was not significantly related to the VEP
parameters (amplitude and peak time) in our cohort.
These findings imply that infants with shorter GA,
irrespective of their clinical status, may have subop-
timal development and compromised integrity of the
visual pathway.
Our results of prolonged and reduced VEPs in pre-
term infants were slightly surprising, given that these
infants were clinically stable and had no signs of
systemic and ocular morbidities except refractive
errors. Previous studies have reported a range of
anomalous flash VEPs in infants born pre-term but all
of those studies involved children with a range of
neurological insults in contrast with our study where
none of the children had features of neurological insult.
Placzek et al. reported flash VEP findings of 70 pre-
term infants and demonstrated that 90% of the
neurologically normal infants had distinct P2 wave-
form found similar to full-term infants from 35 to
36 week’s gestation [11]. However, children with
neurological impairment and brain insults such as
intra-ventricular haemorrhage had immature wave-
forms. Similar findings were reported by De Vries et al.
[12] and Eken et al. [13] who showed pre-term infants
with periventricular leukomalacia had abnormal flash
VEP waveforms (irreproducible waveforms, unable to
record). Nonetheless, a growing body of literature now
suggests an increased vulnerability of visual cortical
function [10], global motion processing, [31] and visual
Fig. 3 Average a P2 peak times and b P2 amplitudes (mean of
two eyes) as functions of predicted values from fixed-effect
models with gestational age (GA) and birth weight (BW) as the
fixed factors. The multiple regression model was significant for
both the P2 peak times and amplitudes, but only gestational age
significantly predicted P2 peak times. The blue lines denote the
fit of the multiple regression models. Each coloured dot
represents an infant. Filled and open circle symbols represent
pre-term and full-term infants, respectively. The grey zones
indicate 95% CI
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sensory and perceptual functioning [32] in infants born
pre-term even in the absence of manifest oculo-visual
and systemic abnormalities. In a sweep VEP study,
Hou et al. studied visual cortical functions in 52 term
infants and 58 very low birth weight and short-
gestation infants without significant retinopathy of
prematurity or neurologic morbidities [10]. They
showed increased threshold and reduction in ampli-
tudes for spatial frequency, contrast, and vernier
displacement measures in pre-term infants at
5–7 months of corrected age when compared with
full-term infants. Hou et al. concluded that pre-term
babies, even in the absence of identifiable retinal or
neurologic abnormalities, demonstrate reduced visual
cortical sensitivity. More recently, Michalczuk et al.
[33] evaluated pattern VEPs in 25 pre-term and 28 term
born school age children and demonstrated reduced
P100 amplitudes and delayed P100 peak times in pre-
term born children compared with those born at term.
Although different forms of VEPs were used to probe
the functionalities of the visual system in the studies by
Chou et al. and Michalczuk et al., their findings are in
line with our results in demonstrating that high-risk
infants even if they do not show any obvious clinical
visual or systemic disorders can still have altered visual
pathway.
Further, and perhaps stronger, evidence comes
from another closely related study in which Feng et al.
[14] tracked flash VEPs in pre-term and full-term
infants from 1 to 18 months following birth and
demonstrated significantly prolonged P2 peak times
and reduced P2 amplitudes in pre-term infants com-
pared with full-term controls. At 6-month corrected
age, the mean P2 peak times of very low birth weight
infants, low birth weight infants, and full-term infants
were 141 ± 19 ms, 135 ± 16 ms and 130 ± 7 ms,
respectively. These values are slightly higher than
those observed in our cohort of pre-term
(133.3 ± 12.7 ms) and full-term children
(122.4 ± 11.4 ms). This discrepancy could be due to
several reasons. First, there were considerable differ-
ences in the stimulation protocol and data extraction
process between this study and the study by Feng et al.,
such as the use of band pass filter (0.5–50 Hz vs
1–100 Hz), the averaging of the waveforms (100 vs
50–100) and the stimulus colour and intensity (red,
3 cd s m-2, vs unspecified). Second, the sample size
in Feng et al.’s study was larger than ours with
considerably higher number of infants in each of the
three groups (20 very low birth weight, 42 low birth
weight and 41 full-term). In contrast, we only had two
groups: 25 pre-term and 25 full-term infants. As there
were only 4 children in the very low birth weight
group, we combined these infants into the low birth
weight group, which resulted in a preponderance of
pre-term infants with low birth weight. Interestingly,
the mean P2 peak time of the low birth weight infant
group in Feng et al.’s study [14] was comparable to the
P2 peak time of pre-term infants in this study. Another
study by Feng et al. [15] reported similar findings of
delayed P2 peak time in pre-term infants as compared
with term infants at the corrected age of 2 years, but
the differences were only significant between the very
low birth weight infants and the control or term
infants. More longitudinal studies are warranted to
unambiguously establish the effect of these subtle
deficits on the visual pathway of pre-term infants for
long-term clinically significant visual outcomes.
Abnormal flash VEPs (amplitude reduction and
peak time delay) in clinically stable pre-term infants as
observed in our study could in part be attributed to the
speed at which the myelination process occurs.
Myelination is a salient feature in neural conduction
and cortical development. It commences before birth
and progresses rapidly in the first few months of life
[34] as evident by the detection of traces of myelin
until 1–2 months of age on T1-weighted MRI [35].
The rates of myelination could vary between infants
born with complete gestational period and those born
pre-term, resulting in lengthening of the peak times
and amplitude drop as observed in the pre-term infants
relative to the full-term infants.
This study has a few limitations. Although our
findings demonstrate subtle differences in VEPs
between pre-term and full-term infants at 6 months
of age, we are unable to generalise the findings beyond
this period due to the cross-sectional nature of the
study. Inferences about the cortical responses were
obtained by simply analysing the P2 component
response of the flash VEP. While the P2 component
is the most prominent feature of the flash VEP [15] and
better relates to the amount of functional neural fibres
and conduction velocity [36], sensory signal integra-
tion and developmental changes in the afferent
pathways are likely to be a complex process. Finally,
our sample size was too small for the stratification of
the results according to the distribution of BW and
GA. Moreover, the small sample size may also limit
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our findings to be generalised to all clinically
stable pre-term infants although power calculation
demonstrated that our study had sufficient power.
In conclusion, pre-term infants, despite being
clinically stable, show prolonged and reduced VEPs
compared with the full-term infants and may be at risk
for a slower maturation and a compromised functional
integrity of the visual pathway. The implications of
these findings for later visual developmental outcomes
remain to be investigated. Further longitudinal studies
would aid in the understanding of the relationship
between these early VEP parameters with the visual
developmental outcomes of clinically stable pre-term
infants later in life.
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